tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Degeeter, 114 are a BUY (93.44%), 7 are a HOLD (5.74%), 1 are a SELL (0.82%).
Analyst Kevin Degeeter works with a stock forecast success ratio of 43.55% fulfilled within 133.1 days on average. Previously, Kevin Degeeter worked at OPPENHEIMER.
Kevin Degeeter’s has documented 221 price targets and ratings displayed on 30 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ANTX, AN2 Therapeutics at 13-Sep-2023.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for NVTA (INVITAE CORP) at 1/12/2021. The price target of $51 was fulfilled within 1 day with a profit of $3.41 (7.17%) receiving and performance score of 71.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$4.94 (466.04%)
1 months 11 days ago
1/6 (16.67%)
$4.79 (395.87%)
157
Buy
6
$4.94 (466.04%)
10
5 months 2 days ago
1/4 (25%)
$4.69 (358.02%)
153
Hold
6
5 months 5 days ago
2/4 (50%)
$4.15 (224.32%)
123
Buy
80
1 years 3 months 13 days ago
2/3 (66.67%)
$58.3 (268.66%)
204
Buy
1 years 9 months ago
2/3 (66.67%)
$64.6 (85.68%)
137
What Year was the first public recommendation made by Kevin Degeeter?
